The Nation - News from April 7, 1986
A drug that shortens the course of herpes infections and apparently lengthens the time between eruptions of herpes-related sores may be a breakthrough in treatment of the incurable disorder, a doctor reported. Details of two studies, appearing in the British journal Lancet, show that when intervir-A--not yet approved by the Food and Drug Administration--was applied to herpes sores, the eruptions quickly disappeared, and incidents of recurrent outbreaks were greatly reduced.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
